FDA finds control lapses at Catalent plant being sold to Novo

By Reuters
| February 08, 2024

The FDA found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a 'pest' on the manufacturing line.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Hospital leaders are increasingly turning to automation to streamline revenue cycle operations, but should some processes be left behind? ...